Antibiotics Market Report 2019-2029

抗生物質の世界市場2019-2029

◆タイトル:Antibiotics Market Report 2019-2029
◆商品コード:VGN910387
◆調査・発行会社:visiongain
◆発行日:2019年8月22日
◆ページ数:170
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Sigle UserGBP3,499 ⇒換算¥461,868見積依頼/購入/質問フォーム
Departmental/Five UserGBP3,899 ⇒換算¥514,668見積依頼/購入/質問フォーム
Site LicenseGBP4,999 ⇒換算¥659,868見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"抗生物質の世界市場2019-2029"について調査・分析し、レポートサマリー、市場動向、主要企業分析などの情報をお届けいたします。

Antibiotics – our new study reveals trends, R&D progress, and predicted revenuesWhere is the Antibiotics market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2029, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 189-page report provides 35 tables, 113 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Antibiotics market. See how to exploit the opportunities.
Forecasts to 2029 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2029, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are 4 segmentations of the Antibiotics market, with forecasts for 4 Class, 3 Drug Origin, 2 Spectrum of Activity and 3 Route of Administration, each forecasted at a global and regional level.
Global Antibiotics Market by Class
• Beta Lactam & Beta Lactamase
• Quinolones
• Macrolides
• Others
Global Antibiotics Market by Drug Origin
• Natural
• Synthetic
• Semi Synthetic
Global Antibiotics Market by Spectrum of Activity
• Broad Spectrum
• Narrow Spectrum
Global Antibiotics Market by Route of Administration
• Oral
• Intravenous
• Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 7 regional and 17 leading national markets:
• North America:
• US
• Canada
• Latin America:
• Brazil
• Mexico
• Rest of Latin America
• Western Europe:
• Germany
• The UK
• Italy
• France
• Spain
• Nordic
• Benelux
• Rest of Western Europe
• Eastern Europe:
• Russia
• Poland
• Rest of Eastern Europe
• Asia-Pacific:
• Japan
• China
• India
• Australia & New Zealand
• ASEAN
• Rest of Asia-Pacific
• MEA:
• GCC Countries
• South Africa
• Northern Africa
• Rest of MEA
The report also includes profiles and for some of the leading companies in the Antibiotics market, with a focus on this segment of these companies’ operations.
There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, Russia, Germany and China in particular, will continue to achieve high revenue growth to 2029.
Leading companies and the potential for market growth
Overall world revenue for Antibiotics will surpass $47.64 billion in 2019, our work calculates. We predict strong revenue growth through to 2029.
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Antibiotics Market report helps you
In summary, our 253-page report provides you with the following knowledge:
• Revenue forecasts to 2029 for 4 segmentations of the Antibiotics market, with forecasts for 4 Class, 3 Drug Origin, 2 Spectrum of Activity and 3 Route of Administration, each forecasted at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2029 for 6 regional and 21 key national markets – See forecasts for the Antibiotics market in North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, the UK, Italy, France, Nordic Countries, Benelux, China, India, Japan, Australia & New Zealand, ASEAN countries, GCC Countries, South Africa and Northern Africa.
• Stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market – including company profiles for 10 of the major companies involved in the Antibiotics market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the Antibiotics Sequencing market and leading companies. You will find data, trends and predictions.
Get our report today The Antibiotics Market Forecast 2019-2029: Revenue Prospects by Class (Beta Lactam & Beta Lactamase, Quinolones, Macrolides, Others), by Drug origin (Natural, Synthetic, Semi Synthetic), by Spectrum of activity (Broad Spectrum, Narrow Spectrum), by Route of Administration (Oral, Intravenous, Others) and Geography.

【レポートの目次】

1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain

2. Antibiotics Market Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Global Antibiotics Market Size and Forecast
2.3. Market Dynamics
2.3.1. Market Drivers
2.3.2. XX
2.3.3. Global Antibiotics Market: Trends
2.3.4. Mergers and Acquisitions
2.3.5. Entry of New Market Players

3. Global Antibiotics Market Analysis and Forecast, By Class
3.1. Introduction
3.1.1. Global Antibiotics Market, Annual Growth Rate Comparison, By Class
3.2. Global Antibiotics Market Size and Forecast, By Class
3.2.1. Beta Lactam & Beta Lactamase
3.2.2. Quinolones
3.2.3. Macrolides
3.2.4. Others
3.3. Global Antibiotics Attractiveness Index, By Class

4. Global Antibiotics Market Analysis and Forecast, By Drug origin
4.1. Introduction
4.1.1. Global Antibiotics Market, Annual Growth Rate Comparison, By Drug origin
4.1.2. Global Antibiotics Market Share Comparison, By Drug origin (2018 & 2029)
4.2. Global Antibiotics Market Size and Forecast, By Drug origin
4.2.1. Natural
4.2.2. Synthetic
4.2.3. Semi Synthetic
4.3. Global Antibiotics Attractiveness Index, By Drug origin

5. Global Antibiotics Market Analysis and Forecast, By Spectrum of activity
5.1. Introduction
5.1.1. Global Antibiotics Market, Annual Growth Rate Comparison, By Spectrum of activity
5.1.2. Global Antibiotics Market Share Comparison, By Spectrum of activity (2018 & 2029)
5.2. Global Antibiotics Market Size and Forecast, By Spectrum of activity
5.2.1. Broad spectrum
5.2.2. Narrow spectrum
5.3. Global Antibiotics Attractiveness Index, By Spectrum of activity

6. Global Antibiotics Market Analysis and Forecast, By Route of administration
6.1. Introduction
6.1.1. Global Antibiotics Market, Annual Growth Rate Comparison, By Route of administration
6.1.2. Global Antibiotics Market Share Comparison, By Route of administration (2018 & 2029)
6.2. Global Antibiotics Market Size and Forecast, By Route of administration
6.2.1. Oral segment
6.2.2. Intravenous segment
6.2.3. Other segments
6.3. Global Antibiotics Attractiveness Index, By Route of administration

7. Global Antibiotics Market Analysis and Forecast, By Region
7.1. Introduction
7.1.1. Global Antibiotics Market, Annual Growth Rate Comparison, By Region
7.1.2. Global Antibiotics Market Share Comparison, By Region (2018 & 2029)
7.2. Global Antibiotics Market Size and Forecast, By Region
7.2.1. North America (U.S., Canada)
7.2.2. Latin America (Brazil, Mexico, Rest of Latin America)
7.2.3. Western Europe (UK, France, Germany, Italy, Spain, Nordic, Benelux, RoWE)
7.2.4. Eastern Europe (Russia, Poland, Rest of Eastern Europe)
7.2.5. Asia Pacific (Japan, China, India, ASEAN, Australia, RoAPAC)
7.2.6. MEA (GCC, South Africa, North Africa, RoMEA)
7.3. Global Antibiotics Market Attractiveness Index, By Region

8. North America Antibiotics Market Analysis and Forecast, 2019–2029
8.1. Introduction
8.1.1. North America Antibiotics Market
8.1.2. North America Antibiotics Market, Annual Growth Rate Comparison, By Country
8.2. North America Antibiotics Market Size and Forecast, By Country
8.2.1. The U.S. Antibiotics Market
8.2.2. Canada Antibiotics Market
8.3. North America Antibiotics Market Size and Forecast, By Class
8.4. North America Antibiotics Market Size and Forecast, By Drug origin
8.5. North America Antibiotics Market Size and Forecast, By Spectrum of activity
8.6. North America Antibiotics Market Size and Forecast, By Route of administration
8.7. North America Antibiotics Market Attractiveness Index
8.8. North America Antibiotics Market Attractiveness Index, By Country
8.9. North America Antibiotics Market Attractiveness Index, By Class
8.10. North America Antibiotics Market Attractiveness Index, By Drug origin
8.11. North America Antibiotics Market Attractiveness Index, By Spectrum of activity
8.12. North America Antibiotics Market Attractiveness Index, By Route of administration

9. Latin America Antibiotics Market Analysis and Forecast, 2019–2029
9.1. Introduction
9.1.1. Latin America Antibiotics Market
9.1.2. Latin America Antibiotics Market, Annual Growth Rate Comparison, By Country
9.2. Latin America Antibiotics Market Size and Forecast, By Country
9.2.1. Brazil Antibiotics Market
9.2.2. Mexico Antibiotics Market
9.2.3. Rest of Latin America Antibiotics Market
9.3. Latin America Antibiotics Market Size and Forecast, By Class
9.4. Latin America Antibiotics Market Size and Forecast, By Drug origin
9.5. Latin America Antibiotics Market Size and Forecast, By Spectrum of activity
9.6. Latin America Antibiotics Market Size and Forecast, By Route of administration
9.7. Latin America Antibiotics Market Attractiveness Index
9.8. Latin America Antibiotics Market Attractiveness Index, By Country
9.9. Latin America Antibiotics Market Attractiveness Index, By Class
9.10. Latin America Antibiotics Market Attractiveness Index, By Drug origin
9.11. Latin America Antibiotics Market Attractiveness Index, By Spectrum of activity
9.12. Latin America Antibiotics Market Attractiveness Index, By Route of administration

10. tern Europe Antibiotics Market Analysis and Forecast, 2019–2029
10.1. Introduction
10.1.1. Western Europe Antibiotics Market
10.1.2. Western Europe Antibiotics Market, Annual Growth Rate Comparison, By Country
10.2. Western Europe Antibiotics Market Size and Forecast, By Country
10.2.1. U.K. Antibiotics Market
10.2.2. France Antibiotics Market
10.2.3. Germany Antibiotics Market
10.2.4. Italy Antibiotics Market
10.2.5. Spain Antibiotics Market
10.2.6. Nordic Antibiotics Market
10.2.7. Benelux Antibiotics Market
10.2.8. Rest of Western Europe Antibiotics Market
10.3. Western Europe Antibiotics Market Size and Forecast, By Class
10.4. Western Europe Antibiotics Market Size and Forecast, By Drug origin
10.5. Western Europe Antibiotics Market Size and Forecast, By Spectrum of activity
10.6. Western Europe Antibiotics Market Size and Forecast, By Route of administration
10.7. Western Europe Antibiotics Market Attractiveness Index
10.8. Western Europe Antibiotics Market Attractiveness Index, By Country
10.9. Western Europe Antibiotics Market Attractiveness Index, By Class
10.10. Western Europe Antibiotics Market Attractiveness Index, By Drug origin
10.11. Western Europe Antibiotics Market Attractiveness Index, By Spectrum of activity
10.12. Western Europe Antibiotics Market Attractiveness Index, By Route of administration

11. Eastern Europe Antibiotics Market Analysis and Forecast, 2019–2029
11.1. Introduction
11.1.1. Eastern Europe Antibiotics Market
11.1.2. Eastern Europe Antibiotics Market, Annual Growth Rate Comparison, By Country
11.2. Eastern Europe Antibiotics Market Size and Forecast, By Country
11.2.1. Russia Antibiotics Market
11.2.2. Poland Antibiotics Market
11.2.3. Rest of Eastern Europe Antibiotics Market
11.3. Eastern Europe Antibiotics Market Size and Forecast, By Class
11.4. Eastern Europe Antibiotics Market Size and Forecast, By Drug origin
11.5. Eastern Europe Antibiotics Market Size and Forecast, By Spectrum of activity
11.6. Eastern Europe Antibiotics Market Size and Forecast, By Route of administration
11.7. Eastern Europe Antibiotics Market Attractiveness Index
11.8. Eastern Europe Antibiotics Market Attractiveness Index, By Country
11.9. Eastern Europe Antibiotics Market Attractiveness Index, By Class
11.10. Eastern Europe Antibiotics Market Attractiveness Index, By Drug origin
11.11. Eastern Europe Antibiotics Market Attractiveness Index, By Spectrum of activity
11.12. Eastern Europe Antibiotics Market Attractiveness Index, By Route of administration

12. Asia Pacific Antibiotics Market Analysis and Forecast, 2019–2029
12.1. Introduction
12.1.1. Asia Pacific Antibiotics Market
12.1.2. Asia Pacific Antibiotics Market, Annual Growth Rate Comparison, By Country
12.2. Asia Pacific Antibiotics Market Size and Forecast, By Country
12.2.1. China Antibiotics Market
12.2.2. India Antibiotics Market
12.2.3. Australia Antibiotics Market
12.2.4. ASEAN Antibiotics Market
12.2.5. Japan Antibiotics Market
12.2.6. Rest of Asia Pacific Antibiotics Market
12.3. Asia Pacific Antibiotics Market Size and Forecast, By Class
12.4. Asia Pacific Antibiotics Market Size and Forecast, By Drug origin
12.5. Asia Pacific Antibiotics Market Size and Forecast, By Spectrum of activity
12.6. Asia Pacific Antibiotics Market Size and Forecast, By Route of administration
12.7. Asia Pacific Antibiotics Market Attractiveness Index
12.8. Asia Pacific Antibiotics Market Attractiveness Index, By Country
12.9. Asia Pacific Antibiotics Market Attractiveness Index, By Class
12.10. Asia Pacific Antibiotics Market Attractiveness Index, By Drug origin
12.11. Asia Pacific Antibiotics Market Attractiveness Index, By Spectrum of activity
12.12. Asia Pacific Antibiotics Market Attractiveness Index, By Route of administration

13. MEA Antibiotics Market Analysis and Forecast, 2019–2029
13.1. Introduction
13.1.1. MEA Antibiotics Market
13.1.2. MEA Antibiotics Market, Annual Growth Rate Comparison, By Country
13.2. MEA Antibiotics Market Size and Forecast, By Country
13.2.1. GCC Antibiotics Market
13.2.2. South Africa Antibiotics Market
13.2.3. North Africa Antibiotics Market
13.2.4. Rest of MEA Antibiotics Market
13.3. MEA Antibiotics Market Size and Forecast, By Class
13.4. MEA Antibiotics Market Size and Forecast, By Drug origin
13.5. MEA Antibiotics Market Size and Forecast, By Spectrum of activity
13.6. MEA Antibiotics Market Size and Forecast, By Route of administration
13.7. MEA Antibiotics Market Attractiveness Index
13.8. MEA Antibiotics Market Attractiveness Index, By Country
13.9. MEA Antibiotics Market Attractiveness Index, By Class
13.10. MEA Antibiotics Market Attractiveness Index, By Drug origin
13.11. MEA Antibiotics Market Attractiveness Index, By Spectrum of activity
13.12. MEA Antibiotics Market Attractiveness Index, By Route of administration

14. Leading Companies in the Antibiotics Market
14.1. Competition Dashboard
14.2. Company Share Analysis
14.3. Company Profiling of 25 Major Players
14.3.1. Company Overview
14.3.2. Class Offerings
14.3.3. Financial Performance (2016-2018)
14.3.4. Recent Initiatives
14.3.5. Average Gross Margin (2016-2018)

15. Conclusion

16. Glossary

17. List of Figures
17.1. Research design
17.2. Market segmentation & scope
17.3. Value chain analysis
17.4. Porter’s Five Forces
17.5. Market summary
17.6. Market driver analysis (Current & Future Impact)
17.7. Market restraint analysis (Current & Future Impact)
17.8. Global Antibiotics Market by Class, 2019-2029 (USD million)
17.9. Global Antibiotics Market for Beta Lactam & Beta Lactamase, 2019-2029 (USD million)
17.10. Global Antibiotics Market for Quinolones, 2019-2029 (USD million)
17.11. Global Antibiotics Market for Macrolides, 2019-2029 (USD million)
17.12. Global Antibiotics Market for Others, 2019-2029 (USD million)
17.13. Global Antibiotics Market by Drug origin, 2019-2029 (USD million)
17.14. Global Antibiotics Market for Natural, 2019-2029 (USD million)
17.15. Global Antibiotics Market for Synthetic, 2019-2029 (USD million)
17.16. Global Antibiotics Market for Semi Synthetic, 2019-2029 (USD million)
17.17. Global Antibiotics Market by Spectrum of activity, 2019-2029 (USD million)
17.18. Global Antibiotics Market for Narrow spectrum, 2019-2029 (USD million)
17.19. Global Antibiotics Market for Broad spectrum, 2019-2029 (USD million)
17.20. Global Antibiotics Market by Route of administration, 2019-2029 (USD million)
17.21. Global Antibiotics Market for oral, 2019 – 2029 (USD million)
17.22. Global Antibiotics Market for intravenous, 2019-2029 (USD million)
17.23. North America Antibiotics Market by Class, 2019-2029 (USD million)
17.24. North America Antibiotics Market for Beta Lactam & Beta Lactamase, 2019-2029 (USD million)
17.25. North America Antibiotics Market for Quinolones, 2019-2029 (USD million)
17.26. North America Antibiotics Market for Macrolides, 2019-2029 (USD million)
17.27. North America Antibiotics Market for Others, 2019-2029 (USD million)
17.28. North America Antibiotics Market by Drug origin, 2019-2029 (USD million)
17.29. North America Antibiotics Market for Natural, 2019-2029 (USD million)
17.30. North America Antibiotics Market for Synthetic, 2019-2029 (USD million)
17.31. North America Antibiotics Market for Semi Synthetic, 2019-2029 (USD million)
17.32. North America Antibiotics Market by Spectrum of activity, 2019-2029 (USD million)
17.33. North America Antibiotics Market for Narrow spectrum, 2019-2029 (USD million)
17.34. North America Antibiotics Market for Broad spectrum, 2019-2029 (USD million)
17.35. North America Antibiotics Market by Route of administration, 2019-2029 (USD million)
17.36. North America Antibiotics Market for oral, 2019 – 2029 (USD million)
17.37. North America Antibiotics Market for intravenous, 2019-2029 (USD million)
17.38. Latin America Antibiotics Market by Class, 2019-2029 (USD million)
17.39. Latin America Antibiotics Market for Beta Lactam & Beta Lactamase, 2019-2029 (USD million)
17.40. Latin America Antibiotics Market for Quinolones, 2019-2029 (USD million)
17.41. Latin America Antibiotics Market for Macrolides, 2019-2029 (USD million)
17.42. Latin America Antibiotics Market for Others, 2019-2029 (USD million)
17.43. Latin America Antibiotics Market by Drug origin, 2019-2029 (USD million)
17.44. Latin America Antibiotics Market for Natural, 2019-2029 (USD million)
17.45. Latin America Antibiotics Market for Synthetic, 2019-2029 (USD million)
17.46. Latin America Antibiotics Market for Semi Synthetic, 2019-2029 (USD million)
17.47. Latin America Antibiotics Market by Spectrum of activity, 2019-2029 (USD million)
17.48. Latin America Antibiotics Market for Narrow spectrum, 2019-2029 (USD million)
17.49. Latin America Antibiotics Market for Broad spectrum, 2019-2029 (USD million)
17.50. Latin America Antibiotics Market by Route of administration, 2019-2029 (USD million)
17.51. Latin America Antibiotics Market for oral, 2019 – 2029 (USD million)
17.52. Latin America Antibiotics Market for intravenous, 2019-2029 (USD million)
17.53. Western Europe Antibiotics Market by Class, 2019-2029 (USD million)
17.54. Western Europe Antibiotics Market for Beta Lactam & Beta Lactamase, 2019-2029 (USD million)
17.55. Western Europe Antibiotics Market for Quinolones, 2019-2029 (USD million)
17.56. Western Europe Antibiotics Market for Macrolides, 2019-2029 (USD million)
17.57. Western Europe Antibiotics Market for Others, 2019-2029 (USD million)
17.58. Western Europe Antibiotics Market by Drug origin, 2019-2029 (USD million)
17.59. Western Europe Antibiotics Market for Natural, 2019-2029 (USD million)
17.60. Western Europe Antibiotics Market for Synthetic, 2019-2029 (USD million)
17.61. Western Europe Antibiotics Market for Semi Synthetic, 2019-2029 (USD million)
17.62. Western Europe Antibiotics Market by Spectrum of activity, 2019-2029 (USD million)
17.63. Western Europe Antibiotics Market for Narrow spectrum, 2019-2029 (USD million)
17.64. Western Europe Antibiotics Market for Broad spectrum, 2019-2029 (USD million)
17.65. Western Europe Antibiotics Market by Route of administration, 2019-2029 (USD million)
17.66. Western Europe Antibiotics Market for oral, 2019 – 2029 (USD million)
17.67. Western Europe Antibiotics Market for intravenous, 2019-2029 (USD million)
17.68. Eastern Europe Antibiotics Market by Class, 2019-2029 (USD million)
17.69. Eastern Europe Antibiotics Market for Beta Lactam & Beta Lactamase, 2019-2029 (USD million)
17.70. Eastern Europe Antibiotics Market for Quinolones, 2019-2029 (USD million)
17.71. Eastern Europe Antibiotics Market for Macrolides, 2019-2029 (USD million)
17.72. Eastern Europe Antibiotics Market for Others, 2019-2029 (USD million)
17.73. Eastern Europe Antibiotics Market by Drug origin, 2019-2029 (USD million)
17.74. Eastern Europe Antibiotics Market for Natural, 2019-2029 (USD million)
17.75. Eastern Europe Antibiotics Market for Synthetic, 2019-2029 (USD million)
17.76. Eastern Europe Antibiotics Market for Semi Synthetic, 2019-2029 (USD million)
17.77. Eastern Europe Antibiotics Market by Spectrum of activity, 2019-2029 (USD million)
17.78. Eastern Europe Antibiotics Market for Narrow spectrum, 2019-2029 (USD million)
17.79. Eastern Europe Antibiotics Market for Broad spectrum, 2019-2029 (USD million)
17.80. Eastern Europe Antibiotics Market by Route of administration, 2019-2029 (USD million)
17.81. Eastern Europe Antibiotics Market for oral, 2019 – 2029 (USD million)
17.82. Eastern Europe Antibiotics Market for intravenous, 2019-2029 (USD million)
17.83. Asia Pacific Antibiotics Market by Class, 2019-2029 (USD million)
17.84. Asia Pacific Antibiotics Market for Beta Lactam & Beta Lactamase, 2019-2029 (USD million)
17.85. Asia Pacific Antibiotics Market for Quinolones, 2019-2029 (USD million)
17.86. Asia Pacific Antibiotics Market for Macrolides, 2019-2029 (USD million)
17.87. Asia Pacific Antibiotics Market for Others, 2019-2029 (USD million)
17.88. Asia Pacific Antibiotics Market by Drug origin, 2019-2029 (USD million)
17.89. Asia Pacific Antibiotics Market for Natural, 2019-2029 (USD million)
17.90. Asia Pacific Antibiotics Market for Synthetic, 2019-2029 (USD million)
17.91. Asia Pacific Antibiotics Market for Semi Synthetic, 2019-2029 (USD million)
17.92. Asia Pacific Antibiotics Market by Spectrum of activity, 2019-2029 (USD million)
17.93. Asia Pacific Antibiotics Market for Narrow spectrum, 2019-2029 (USD million)
17.94. Asia Pacific Antibiotics Market for Broad spectrum, 2019-2029 (USD million)
17.95. Asia Pacific Antibiotics Market by Route of administration, 2019-2029 (USD million)
17.96. Asia Pacific Antibiotics Market for oral, 2019 – 2029 (USD million)
17.97. Asia Pacific Antibiotics Market for intravenous, 2019-2029 (USD million)
17.98. MEA Antibiotics Market by Class, 2019-2029 (USD million)
17.99. MEA Antibiotics Market for Beta Lactam & Beta Lactamase, 2019-2029 (USD million)
17.100. MEA Antibiotics Market for Quinolones, 2019-2029 (USD million)
17.101. MEA Antibiotics Market for Macrolides, 2019-2029 (USD million)
17.102. MEA Antibiotics Market for Others, 2019-2029 (USD million)
17.103. MEA Antibiotics Market by Drug origin, 2019-2029 (USD million)
17.104. MEA Antibiotics Market for Natural, 2019-2029 (USD million)
17.105. MEA Antibiotics Market for Synthetic, 2019-2029 (USD million)
17.106. MEA Antibiotics Market for Semi Synthetic, 2019-2029 (USD million)
17.107. MEA Antibiotics Market by Spectrum of activity, 2019-2029 (USD million)
17.108. MEA Antibiotics Market for Narrow spectrum, 2019-2029 (USD million)
17.109. MEA Antibiotics Market for Broad spectrum, 2019-2029 (USD million)
17.110. MEA Antibiotics Market by Route of administration, 2019-2029 (USD million)
17.111. MEA Antibiotics Market for oral, 2019 – 2029 (USD million)
17.112. MEA Antibiotics Market for intravenous, 2019-2029 (USD million)
17.113. List of Companies

18. List of Tables
18.1. Global Antibiotics Market, by Class, 2019-2029 (USD million)
18.2. Global Antibiotics Market, by Drug origin, 2019-2029 (USD million)
18.3. Global Antibiotics Market, by Spectrum of activity, 2019-2029 (USD million)
18.4. Global Antibiotics Market, by Route of administration, 2019-2029 (USD million)
18.5. North America Antibiotics Market, 2019-2029 (USD million)
18.6. U.S. Antibiotics Market, 2019-2029 (USD million)
18.7. Canada Antibiotics Market, 2019-2029 (USD million)
18.8. Latin America Antibiotics Market, 2019-2029 (USD million)
18.9. Brazil Antibiotics Market, 2019-2029 (USD million)
18.10. Mexico Antibiotics Market, 2019-2029 (USD million)
18.11. Rest of Latin America Antibiotics Market, 2019-2029 (USD million)
18.12. Western Europe Antibiotics Market, 2019-2029 (USD million)
18.13. UK Antibiotics Market, 2019-2029 (USD million)
18.14. France Antibiotics Market, 2019-2029 (USD million)
18.15. Germany Antibiotics Market, 2019-2029 (USD million)
18.16. Italy Antibiotics Market, 2019-2029 (USD million)
18.17. Nordic Antibiotics Market, 2019-2029 (USD million)
18.18. Benelux Antibiotics Market, 2019-2029 (USD million)
18.19. Rest of Western Europe Antibiotics Market, 2019-2029 (USD million)
18.20. Eastern Europe Antibiotics Market, 2019-2029 (USD million)
18.21. Russia Antibiotics Market, 2019-2029 (USD million)
18.22. Poland Antibiotics Market, 2019-2029 (USD million)
18.23. Rest of Eastern Europe Antibiotics Market, 2019-2029 (USD million)
18.24. Asia Pacific Antibiotics Market, 2019-2029 (USD million)
18.25. Japan Antibiotics Market, 2019-2029 (USD million)
18.26. India Antibiotics Market, 2019-2029 (USD million)
18.27. Australia Antibiotics Market, 2019-2029 (USD million)
18.28. ASEAN Antibiotics Market, 2019-2029 (USD million)
18.29. China Antibiotics Market, 2019-2029 (USD million)
18.30. Rest of Asia Pacific Antibiotics Market, 2019-2029 (USD million)
18.31. MEA Antibiotics Market, 2019-2029 (USD million)
18.32. South Africa Antibiotics Market, 2019-2029 (USD million)
18.33. North Africa Antibiotics Market, 2019-2029 (USD million)
18.34. GCC Antibiotics Market, 2019-2029 (USD million)
18.35. Rest of MEA Antibiotics Market, 2019-2029 (USD million)
Companies Listed: Antibiotics Market



★調査レポート[抗生物質の世界市場2019-2029] ( Antibiotics Market Report 2019-2029 / VGN910387) 販売に関する免責事項
[抗生物質の世界市場2019-2029] ( Antibiotics Market Report 2019-2029 / VGN910387) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆